Eosinophil trafficking to sites of allergic inflammation

Immunological Reviews

Volumn 179, Issue , 2001, Pages 163-172

  Broide, David ^a,b,c   Sriramarao, P ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CHEMOKINE; CYTOKINE; INTERLEUKIN 5; NERVE CELL ADHESION MOLECULE;

ALLERGENICITY; BONE MARROW; DNA SEQUENCE; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; MICROSCOPY; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BONE MARROW; CELL ADHESION; CELL ADHESION MOLECULES; CHEMOKINES; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; ENDOTHELIUM, VASCULAR; EOSINOPHILIA; EOSINOPHILS; FIBRONECTINS; HEMATOPOIESIS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INTEGRINS; INTERLEUKIN-1; INTERLEUKIN-5; MICE; MICE, KNOCKOUT; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, DNA;

EID: 0035105765     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.790116.x     Document Type: Review

References (90)

1. Eosinophilic inflammation in asthma
2. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
3. Lung immunopathology in cases of sudden asthma death
4. Human eosinophils
5. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics
6. Inhibition of eosinophil rolling and recruitment in P-selectin and ICAM deficient mice
7. Inhibition of eosinophilic inflammation in allergen-challenged IL-1 receptor type I deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium
8. Interleukin-5 deficiency abolishes eosinophilia, airway hyperreactivity and lung damage in a mouse asthma model
9. Eosinophilia in transgenic mice expressing interleukin 5
10. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
11. Cytokines in symptomatic asthma airways
12. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma
13. Interleukin-1 is released at sites of human cutaneous allergic reactions
14. Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor
15. Allergen exposure induces the expression of endothelial adhesion molecules in passively sensitized human bronchus: Time course and the role of cytokines
16. Human aortic endothelial cells express the type I but not the type II receptor for interleukin-1 (IL-1)
17. Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation
18. Interleukin 1α and interleukin 1β bind to the same receptor on T cells
19. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type 1 receptor-deficient mice
20. Interleukin-4, -5 and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
21. TNF-α mRNA expression in allergic inflammation
22. Tumor necrosis factor causes bronchial hyperresponsiveness in rats
23. Tumor necrosis factor's effects on lung mechanics, gas exchange, and airway reactivity in sheep
24. TNF-α increases airway responsiveness and sputum neutrophilia in normal human subjects
25. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering
26. TNF-α is important in human lung allergic reactions
27. TNF-α and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation
28. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1
29. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration
30. Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-r55
31. Tumor necrosis factor-α induces leukocyte recruitment by different mechanisms in vivo and in vitro
32. Inhibition of eosinophilic inflammation in TNF receptor p55/p75 and TNF receptor p55 deficient mice
33. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
34. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
35. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: Relationship to eosinophil, T cell, and macrophage recruitment
36. Bronchial hyperreactivity in CR3 deficient mice
37. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo
38. Cellular adhesion and its antagonism
39. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo
40. Comparison of human eosinophil and neutrophil ligands for P-selectin: Ligands for P-selectin differ from those from E-selectin
41. Adhesion of human basophils, eosinophils, and neutrophils to IL-1 activated human vascular endothelial cells: Contributions of endothelial cell adhesion molecules
42. Mechanisms of eosinophil adherence to cultured vascular endothelial cells: Eosinophils bind to cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor
43. Comparison of human eosinophil and neutrophil adhesion to endothelial cells under nonstatic conditions. Role of L-selectin
44. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent
45. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue
46. Human eosinophil, but not neutrophil, adherence to IL-1 stimulated human umbilical vascular endothelial cells is α4β1 (very late antigen-4) dependent
47. Expression and function of the MAdCAM-1 receptor, integrin α4β7 on human leukocytes
48. Integrin α4β7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin
49. Functional and structural characterization of the eosinophil P-selectin ligand
50. VCAM-1 is more effective than MAdCAM-1 in supporting eosinophil rolling under conditions of flow
51. E-selectin preferentially supports neutrophil but not eosinophil rolling under conditions of flow in vitro and in vivo
52. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multi-step paradigm
53. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1
54. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow
55. Chemokines-chemotactic cytokines that mediate inflammation
56. Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (α4β1)
57. Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4
58. Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule- 1 at 1.8A resolution
59. α4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep
60. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo
61. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways
62. Blockade of CD49d (α4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
63. Adhesion to fibronectin prolongs eosinophil survival
64. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation
65. Granulocyte-macrophage colony-stimulating factor regulates the functional adhesive state of very late antigen-4 expressed by eosinophils
66. Regulation of α4 integrin-mediated adhesion of human eosinophils to fibronectin and vascular cell adhesion molecule-1
67. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1
68. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow
69. C3a and C5a mediate the rapid activation dependent conversion of rolling eosinophils to firmly adherent eosinophils in vivo
70. A role for the C3a anaphylatoxin receptor in the effector phase of asthma
71. On the crawling of animal cells
72. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1
73. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils
74. Cloning, expression, and characterization of the human eosinophil eotaxin receptor
75. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
76. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
77. IIb
78. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration
79. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases
80. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration
81. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization
82. Differential regulation of β1 and β2 integrin avidity by chemoattractants in eosinophils
83. The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow
84. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice
85. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
86. Long-term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides
87. How BCG led to the discovery of immunostimulatory DNA
88. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
89. Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro
90. CpG motifs in bacterial DNA trigger direct B-cell activation